PVCT Provectus Biopharmaceuticals - Correlation between Tumor Mutational Burden and Objective Response Rate with Anti–PD-1 or Anti-PD–L - PVCT Provectus Biopharmaceuticals - InvestorVillage
PVCT Provectus Biopharmaceuticals
This is a semi-private group. You are free to browse messages, but you must be a member of this group to post messages. Join This Group

Group: PVCT Provectus Biopharmaceuticals   /  Message Board  /  Read Message

 
 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  4319 of 4353  at  7/11/2019 11:21:57 AM  by

Hombre77

The following message was updated on 7/11/2019 11:23:47 AM.

 In response to msg 4318 by  PVCTismyBMW
view thread

Re: Correlation between Tumor Mutational Burden and Objective Response Rate with Anti–PD-1 or Anti-PD–L1 Therapy in 27 Tumor Types

  
I agree with everything you wrote. Which is why I'm lukewarm to LTG's comment about PVCT being acquired prior to an FDA approval -  I just don't see how a decent valuation could realistically be achieved in such a scenario.
 
Perhaps I'm being somewhat naive, but I don't see that Provectus has a lot of bargaining power with BP at the moment, so any type of financing / trial partnership is likely to come at a high price -  e.g. conceding significant future rights to the sponsoring company. 
 
I'm very aware that this is an unusual situation, but it's the current reality so in the absence of a miracle, I don't see any prospect of a near-term buyout at an acceptable price (absent an FDA approval).  The only way I can see a buyout prior to FDA approval is if it includes Contingent Value Rights (a CVR - see link below) that would allow current shareholders to participate in future upside.
 
I would love to be wrong, so if anybody has ideas for an alternative path forward that could bring the share price to a level that would ultimately facilitate an acquisition at a price exceeding $1.00, I'd be very interested in hearing about it. 
 
 
 
 
 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 173
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...